Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Tissue Engineering and Regenerative Medicine Workshop Held in Kobe
December 19, 2005
- Korosho Proposes Direction for FY2006 NHI Pricing System Reform
December 19, 2005
- Requirements for DPC Hospitals Proposed by Korosho
December 19, 2005
- (Proposed) Direction for FY2006 NHI Pricing System Reform
December 19, 2005
- Pollinosis Much More Common in Boys Under 10 Years of Age
December 19, 2005
- Korosho's Reform Proposal Would Weaken Industry: Mr Crenshaw of PhRMA
December 19, 2005
- Airborne Cedar Pollen Levels Should Be Lower in 2006
December 19, 2005
- Long-listed Drugs' NHI Price Reductions to Negatively Affect State Finances: OPIR
December 19, 2005
- JSCPT Annual Assembly Held in Beppu
December 19, 2005
- EU Directive Effective in Improving Both Speed and Quality: QTJ
December 19, 2005
- R＆D NEWS IN BRIEF
December 19, 2005
- OPINION
December 19, 2005
- SYNPOSIUM
December 19, 2005
- SELF-MEDICATION NEWS IN BRIEF
December 19, 2005
- JPA Criticizes Gov't Framework for HC Reform
December 19, 2005
- Aska Pharm. to Promote Lipidil, Expand Generic Business: President Yamaguchi
December 19, 2005
- REGULATORY NEWS IN BRIEF
December 19, 2005
- Aiming at Global Top 10: Astellas
December 19, 2005
- President & CEO Stephen J. Ubl Meets Japanese Stakeholders: AdvaMed
December 19, 2005
- Pegintron, Rebetol Show Strong Growth in Japan: Schering-Plough
December 19, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…